Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal

Sateesh Krishnamurthy1, Toru Takimoto, Ruth Ann Scroggs

  • 1Department of Infectious Diseases, Mail Stop 330, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794, USA.

Journal of Virology
|May 16, 2006
PubMed

Insights

Newcastle disease virus (NDV) shows different infection patterns in normal versus tumor cells. Tumor cells exhibit a weaker antiviral response to interferon-beta (IFN-beta), enabling rapid NDV spread.

Area of Science:

  • Virology
  • Oncolytic Viruses
  • Immunology

Background:

  • Newcastle disease virus (NDV) is a negative-strand RNA virus with demonstrated oncolytic activity against human tumors.
  • Clinical studies show NDV's effectiveness against tumors and safety in normal tissues.
  • Differences in NDV infection spread and cellular response to interferon-beta (IFN-beta) between normal and tumor cells are observed.

Purpose of the Study:

  • To investigate the differential response of normal and tumor cells to NDV infection and IFN-beta treatment.
  • To compare the IFN signal transduction pathway in normal versus tumor cells.
  • To elucidate the mechanisms behind NDV's differential spread and replication.

Main Methods:

  • Comparative analysis of NDV replication and spread in HT-1080 (tumor) and CCD-1122Sk (normal) cell lines.
  • Assessment of NDV replication inhibition by IFN-beta in both cell types.
  • Analysis of IFN signal transduction pathway components (phosphorylated STAT1/STAT2, ISGF3 complex) via Western blot or similar techniques.
  • Gene expression profiling using cDNA microarrays to compare IFN-regulated genes.

Main Results:

  • NDV replicated rapidly and killed HT-1080 cells, but spread poorly in CCD-1122Sk cells.
  • IFN-beta pretreatment completely inhibited NDV replication in normal cells but had minimal effect on tumor cells.
  • Tumor cells showed reduced levels of phosphorylated STAT1, STAT2, and the ISGF3 complex upon IFN-beta treatment.
  • Fewer IFN-regulated genes were identified in tumor cells compared to normal cells, indicating a deficient antiviral response.

Conclusions:

  • Tumor cells possess a deficient IFN signal transduction pathway, leading to a less-than-optimum antiviral response.
  • The impaired IFN response in tumor cells allows for the rapid spread of NDV.
  • The differential response to IFN-beta is a key factor determining the outcome of NDV infection in normal versus tumor cells.